IVIG Infusions Deplete Donor-Specific HLA Antibodies in Lung Transplant Recipients

被引：0
|
作者：
Kukreja, J. [1 ]
Kopchaliiska, D. [2 ]
Dincheva, G. [1 ]
Bush, E. [1 ]
Leard, L. [3 ]
Brzezinski, M. [4 ]
Hays, S. [3 ]
Singer, J. [3 ]
Rajalingam, R. [2 ]
机构：
[1] Univ Calif San Francisco, Div Cardiothorac Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Div Pulm Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 04期
关键词：
D O I：
10.1016/j.healun.2016.01.671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
642
引用
收藏
页码：S236 / S237
页数：2
相关论文
共 50 条
  • [1] IVIG INFUSIONS DEPLETE DONOR-SPECIFIC HLA ANTIBODIES IN LUNG TRANSPLANT RECIPIENTS: A SINGLE-CENTER EXPERIENCE.
    Kopchaliiska, Dessislava
    Kukreja, Jasleen
    Dincheva, Gabriela
    Bush, Errol
    Leard, Lorriana
    Singer, Jonathan
    Brzezinski, Marek
    Hays, Steven
    Rajalingam, Raja
    [J]. HUMAN IMMUNOLOGY, 2015, 76 : 14 - 14
  • [2] A Peritransplant Strategy in Lung Transplant Recipients with Preformed HLA Donor-Specific Antibodies (pDSA)
    Parquin, F.
    Devaquet, J.
    Larbi, A. Si
    Cuquemelle, E.
    Roux, A.
    Cerf, C.
    Picard, C.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S192 - S193
  • [3] Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients
    Levitsky, J.
    Kaneku, H.
    Jie, C.
    Walsh, R. C.
    Abecassis, M.
    Tambur, A. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (08) : 2437 - 2444
  • [4] Donor-Specific Antibodies in Kidney Transplant Recipients
    Zhang, Rubin
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (01): : 182 - 192
  • [5] Donor-specific HLA antibodies and transplant outcomes
    [J]. Nature Reviews Nephrology, 2012, 8 (8) : 433 - 433
  • [6] Postoperative outcomes of lung transplant recipients with preformed donor-specific antibodies
    Kayawake, Hidenao
    Chen-Yoshikawa, Toyofumi F.
    Gochi, Fumiaki
    Tanaka, Satona
    Yurugi, Kimiko
    Hishida, Rie
    Yutaka, Yojiro
    Yamada, Yoshito
    Ohsumi, Akihiro
    Hamaji, Masatsugu
    Nakajima, Daisuke
    Date, Hiroshi
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 32 (04) : 616 - 624
  • [7] Effects of Donor-Specific HLA Antibodies and Non-HLA Antibodies on AMR in Renal Transplant Recipients
    Lee, H.
    Shin, K.
    Kim, I.
    Choi, B.
    Kim, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S692 - S693
  • [8] Donor-Specific Antibodies Among Lung Transplant Recipients with Short Telomeres
    Fan, R.
    Ghosh, S.
    Madala, N.
    Varghese, J.
    Torres, F.
    Bollineni, S.
    Banga, A.
    Mohanka, M.
    Joerns, J.
    Lawrence, A.
    Garcia, C. K.
    Newton, C.
    Kaza, V.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?
    Pascual, J.
    Arns, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2561 - 2562
  • [10] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
12345